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Abstract.  Immature Schwann cells of the rat sciatic 
nerve can differentiate into myelin-forming or non- 
myelin-forming cells.  The factors that influence this 
divergent development are unknown but certain mark- 
ers such as galactocerebroside distinguish the two cell 
populations at an early stage of Schwann cell differen- 
tiation. Because myelination requires extensive changes 
in cell morphology,  we have investigated the composi- 
tion and  structure of the Schwann cell cytoskeleton at 
a time whean these cells become committed to myelina- 
tion.  Here we show that Schwann cells express a cyto- 
skeletal protein of Mr  145 before diverging  into the 
myelin-forming path,  i.e.,  before they acquire cell-sur- 
face galactocerobroside. The p145 protein has the char- 
acteristics of an intermediate filament (IF) protein and 
immunoelectron microscopy shows that it colocalizes 
with vimentin,  which suggests that these two proteins 
can coassemble into IFs.  Elevated intracellular  cAMP 
levels, which can mimic some of the early effects of 
axons on Schwann cell differentiation,  induced p145 
synthesis,  therefore,  we conclude that myelin-forming 
Schwann cells express this protein at a very early stage 
in their development. Immunological comparisons with 
other IF proteins revealed a close similarity between 
p145 and the neurofilament protein NF-M; the iden- 
tification of p145 as NF-M was confirmed by isolat- 
ing and sequencing a full-length clone from a Schwann 
cell cDNA library.  These data demonstrate that Schwarm 
cells remodel their IFs by expressing NF-M before ac- 
quiring the myelin-forming phenotype and that IF pro- 
teins of the neurofilament-type are not restricted to 
neurons in the vertebrate nervous system. 
CHWANN cells differentiate  into either a myelin-form- 
ing or a non-myelin-forming  type during the develop- 
ment of the peripheral nervous system (for a review, see 
Jessen and  Mirsky,  1991). As a  result of axonal  contact, 
myelin-forming  Schwann  cells acquire  the differentiation- 
specific glycolipid galactocerebroside (GalC) ~ around em- 
bryonic day 18 (El8) at a time when larger axons segregate 
into  1:1 units with Schwann cells (Eccleston et al.,  1987); 
non-myelin-forming  Schwann cells express GalC much later 
between postnatal weeks 2-5 (Jessen and Mirsky,  1985; Jes- 
sen et al., 1987). Close contact with axons is also necessary 
for the expression of a second glycolipid,  sulfatide, which is 
identified  by the mAb 04 (Sommer and  Schachner,  1981; 
Mirsky et al., 1990); however, unlike GalC, 04 is expressed 
in both types of Schwann cell in the rat sciatic nerve at an 
early stage (Mirsky et al., 1990). By El8, Schwann cells also 
express a distinct set of proteins including A5E3, Ran-l, and 
glial fibrillary  acidic protein (GFAP) (Jessen et al.,  1990). 
In  non-myelin-forming  Schwann  cells,  Ran-I,  A5E3,  and 
GFAP persist into adulthood whereas all three proteins are 
down-regulated  in myelinating  Schwann cells. 
Axonal contact stimulates Schwann cell proliferation  (Sal- 
zer and Bunge,  1980; DeVries et al.,  1982; Sobue and Plea- 
1. Abbreviations  used in this paper:  GalC,  glycolipid galactocerebroside; 
GFAP, glial fibrillary acidic protein; IE  intermediate filament. 
sure,  1985),  basement membrane formation  (Bunge et al., 
1986), and is also critical for myelin synthesis (Mirsky et al., 
1980; Bunge et al., 1986; Lemke and Chao,  1988; Brunden 
et al.,  1990).  Some of the results of axonal contact such as 
Schwann cell proliferation  and the cell surface expression of 
GalC can be mimicked in vitro by cAMP and its analogues 
(Sobue and Pleasure, 1984,  1986; Porter et al.,  1986). Re- 
cently, Morgan et al. (1991) showed that the myelin-forming 
phenotype  (up-regulated  Po  and  down-regulated  Ran-l, 
A5E3, and GFAP) could be induced in quiescent dissociated 
Schwann cells by raising  intracellular  cAMP levels. In con- 
trast,  04 expression  was equally inducible  in dividing  and 
nondividing  cells. 
Myelination requires dramatic changes in the shape of the 
Schwann cell which must involve the cytoskeleton. Indeed 
the cytoskeleton of oligodendrocytes has already been shown 
to be intimately involved in the extension of myelin processes 
in the rat central nervous system (Wilson and Brophy, 1989). 
In most eukaryotic cells the cytoskeleton consists ofmicrotu- 
bules (diameter  25 nm),  microfilarnents  (diameter  5-7 nm), 
and intermediate  filaments  (IFs) (diameter 10 nm).  IFs are 
morphologically similar in most eukaryotic cell types but 
they show a wide heterogeneity in their polypeptide subunits 
and these have been divided into six classes:  types I and II 
(keratins  in  epithelial  cells),  type III  (vimentin,  desmin, 
GFAP, peripherin), type IV (the neurofilaments NF-L, NF-M 
￿9  The Rockefeller University Press, 0021-9525/92/07/397/14 $2.00 
The Journal of Cell Biology, Volume 118, Number 2, July 1992 397-410  397 Figure 1. Immunoblot of cyto- 
skeleton (C) and soluble (S) 
fractions of Schwarm  cells (80 
/~g protein) from 5-d rat sciatic 
nerves as described in Materi- 
als and Methods. (1) Proteins 
stained with Amido Black; (2) 
immunoblot with  antivimen- 
tin; (3) immunoblot with anti- 
p145. Both vimentin and p145 
were  exclusively  associated 
with the Schwann cell cyto- 
skeleton and their  respective 
antibodies were specific. 
and NF-H of apparent molecular masses 68,  150, and 200 
kD, respectively, and tx-internexin), type V (nuclear lamins), 
and  type VI  (nestin)  (Lendahl et  al.,  1990;  Steinert and 
Liem, 1990; Chin et al.,  1991). Since IF proteins are often 
specifically expressed in particular cell types, they have been 
used as differentiation markers and as such are useful tools 
in  the  study  of cell  differentiation as  well  as  in  tumour 
identification (Osborn and Weber,  1983). 
All IF proteins share common structural features: they are 
all rod-shaped and have a  large, highly conserved central 
u-helical core domain of ,,o 310 residues which is flanked by 
two nonhelical terminal domains of variable length and se- 
quence at the amino-and carboxy-terminal regions (Weber 
et al., 1983; Monteiro and Cleveland, 1989). Despite exten- 
sive knowledge of their amino acid and cDNA sequences, the 
physiological function of most IF proteins remains elusive. 
Their linkage to both nucleus and plasma membrane (Geor- 
gatos et al., 1987) suggests a general role in the spatial orga- 
nization of the cytoplasm; alternatively, IFs may be involved 
either in the transport of macromolecules between the nu- 
cleoplasmic and cytoplasmic compartments or in the trans- 
duction of information from the cell periphery to the nucleus 
(Geiger,  1987;  Goldman et al.,  1985).  Recent transfection 
experiments have shown that GFAP is required for the forma- 
tion of stable astrocytic processes in  response to neurons 
(Weinstein et al.,  1991), and neurofilaments may determine 
axonal caliber (Hoffman et al.,  1983), although the results 
of recent transgenic experiments in mice argue to the con- 
trary (Monteiro et al.,  1990). 
IFs  are  commonly  remodelled  during  cell  maturation 
which suggests that the IF network has a  role in differen- 
tiation. Thus, vimentin is exchanged for desmin in the IFs of 
developing  muscle  cells  (Lazarides,  1982;  Cossette  and 
Vincent,  1991), and there are dramatic changes in the com- 
position of IF networks during neuronal development. Neu- 
roepithelial stem cells initially coexpress nestin and vimentin 
(Lendahl et  al.,  1990),  but nestin  is  subsequently down- 
regulated and the type IV  IF protein o~-internexin appears 
(Fliegner et al.,  1990). a-Internexin is in turn replaced by 
the type IV proteins NF-L, NF-M, and NF-H that are char- 
acteristic of mature neurons (Steinert and Liem, 1990). The 
phenomenon of altered IF protein expression during termi- 
nal differentiation is also evident in glia. Mature oligoden- 
drocytes lack IF proteins but their progenitors possess vimen- 
tin (Noble et al., 1990). Similarly, vimentin is the IF protein 
of immature Schwann cells although,  unlike oligodendro- 
cytes, vimentin is retained in differentiated cells (Autilio- 
Gambetti et al.,  1982). A second IF protein, GFAP, appears 
in Schwann cells at El8 (Jessen and Mirsky,  1991) but the 
expression of GFAP is suppressed upon terminal differentia- 
tion of myelin-forming Schwann cells, while it is retained in 
non-myelin-forming Schwann cells (Jessen et al.,  1990). 
We are interested in the role of the cytoskeleton in the dif- 
ferentiation of myelin-forming cells and in how the cytoskel- 
eton regulates the extension of myelin processes during axo- 
nal ensheathment. In this paper we describe a Schwann cell 
IF protein that is expressed at an early stage in the differ- 
entiation program of myelin-forming Schwann  cells.  This 
protein,  which  we  initially  called  p145,  colocalizes with 
Figure 2. Immunofluorescence localization of p145 in Schwann cell cytoskeletons. Cells were grown on poly-D-lysine-coated plastic for 
24 h before extraction. Cytoskeletons were viewed with (A) phase-contrast optics and (B) rhodamine optics to visualize p145. Note the 
filamentous staining in the lower cell. Bar,  10/~m. 
The Journal of Cell Biology,  Volume 118, 1992  398 Figure 3. Double-label immunofluorescence  localization of p145 and vimentin  in Schwann cell cultures treated with colchicine. Cells were 
viewed before colchicine by (.4) phase contrast, (B)  rhodamine optics for p145,  and (C) fluorescein optics for vimentin. Note that the 
fibroblast has virnentin but does not contain p145. Colchicine-treated cells are shown by (D) phase-contrast optics, (E) rhodamine optics 
for p145,  and (F) fluorescein optics for vimentin. Both p145 and vimentin have retracted to a perinuclear location. Bar,  10/~m. 
vimentin and is inducible in culture by cAMP analogues. Im- 
munological analysis suggested that p145 might be identical 
to the neurofitament protein NF-M, and this hypothesis was 
confirmed by cDNA cloning. 
Materials and Methods 
Schwann Cell Cultures 
Sciatic nerves from 1-5-d-old embryonic rats and pups were dissected and 
dissociated according to the method of Brockes et al. (1979) and the cells 
were seeded on either 13-mm  glass coverstips (BDH, Glasgow, Scotland) or 
plastic 35-ram dishes (Costar Data Packaging Corp., Cambridge, MA) that 
had been coated with 100 #g/mi poly-o-lysine (Sigma Chemical Co., St. 
Louis, MO). Cultures were maintained in Optimem (Gibco-BRL, Grand 
Island, NY) containing 10% FCS (Flow Laboratories, Inc., McLean, VA). 
Cell Culture in the Presence of  cAMP  Analogues 
To examine the effects of raised intracellular cAMP levels in Schx~ann  cells, 
cultures from sciatic nerves of  5-d rat pups were grown for 24 h in Optimem 
containing 10% FCS. The cells were rinsed three times with Optimem and 
then refed in medium containing 5 ￿  10  -4 M N  6, 2'-O-dibutyryladenosine 
3':5'-cyclic monophosphate (db-cAMP) (Sigma Chemical Co.) for 48 h in 
the presence or absence of FCS with media changes every 24 h. Control 
cultures were refed with fresh Optimem containing 10% FCS every 24 h. 
Kelly et al. Schwann Cells and h~-M  399 Figure 4.  Immunoelectron localization of p145 and vimentin in Schwann cells.  Cytoskeletons were immunostained with p145 antibody 
and vimentin mAb and then reacted with secondary antibodies that were labeled with colloidal gold particles. IFs were clearly immuno- 
stained for both p145 (10 ran gold) and vimentin (5 rim gold) (,4 and B).  Schwann cell IFs composed only of vimentin which were not 
labeled with anti-p145 are shown in C.  Bars, 0.1  #m. 
In experiments designed  to  induce expression of Po,  we  used  a  slight 
modification of the protocol  of Morgan et al. (1991). Briefly, after cell cul- 
ture for 24 h in Optimem containing 10% FCS,  10  -5 M cytosine arabino- 
side (Sigma Chemical  Co.) was added  for 48 h after which time cultures 
were returned to Optimem containing 10% FCS for a further 24 h. On the 
fifth day, cAMP analogues db-cAMP and 8-bromoadenosine-cAMP (Sigma 
Chemical Co.) each at 5 x  10  -4 M were added to Optimem containing 2% 
FCS. On the sixth day, medium was replenished, but the concentration of 
each cAMP analogue was reduced to 5  x  10  -s M. After a further 24 h, 
the medium was replaced by serum-free Optimem containing  the cAMP an- 
alogues.  Finally, on the eighth day of culture, cells were processed for in- 
direct immunofluorescence.  Control cultures  were maintained throughout 
in Optimem containing 10% FCS and were refed every 24 h. 
Preparation of Cytoskeleton Fractions  from 
Schwann Cells 
Cell cultures were extracted at room temperature for 3 min with the extrac- 
tion buffer described by Wilson and Brophy (1989) (10 mM Pipes, pH 6.9, 
50 mM KCI, 2 mM EGTA,  1 mM MgCI2, 2 M glycerol,  10 ~g/ml leupep- 
tin (Sigma Chemical Co.), and 10 ~g/ml antipain (Sigma Chemical Co.), 
containing 0.5%  (vol/vol)  Triton  X-100).  The  cytoskeletons  were  then 
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1) or recombinant)~gtl  1 containing SNPI011 isolated from a rat sci- 
atic nerve library (lane 2) and Schwann cells (lane 3) were electro- 
phoresed on 5-17 % polyacrylamide gels and transferred to nitrocel- 
lulose.  An antibody (A//) was  raised against the/$-galactosidase 
fusion protein that had been expressed in the recombinant cells. Im- 
munoblotting showed that, as expected, Schwann cell #45 was rec- 
ognized by both anti-#45  (A) and AI1  (B) confirming that #45 
contained NF-M sequences. The low Mr bands detected by AI1 in 
lanes 1 and 2  are presumably proteolytic breakdown products. (b) 
NF-M is immunologically related to #45. Schwann cells from 5-d 
rat sciatic nerve were cultured for 16 h, solubilized in SDS-PAGE 
sample buffer, and analyzed by immunoblotting. Both AI1 (lane 2) 
and Dahl's rabbit anti-NF-triplet antibody (lane 3) recognize a pro- 
tein with the same Mr as #45,  which is shown in lane  1 stained 
with anti-p145. 
washed in the same buffer without Triton X-100 before  being fixed and 
processed for indirect immunofluorescence.  For Western blotting,  extract 
and wash were pooled and centrifuged  at 14,000 g for 10 rain after which 
the supernatant was designated the soluble fraction.  Cytoskeletons were 
scraped off with a rubber policeman and sedimented by centrifugation at 
14,000 g for 10 rain. 
Antibodies 
Gifts of the following antibodies are gratefully  acknowledged.  They were 
used  at the  indicated dilutions for  immunofluorescence  and they  were 
diluted  a  further  10-fold  for  immunoblotting:  rabbit anti-S100  (J.  E. 
Hesketh, Rower Research Institute, Aberdeen, Scotland)  (1:5,000); rabbit 
antivimentin (R. O. Hynes, M.LT., Cambridge, MA) (1:200); rabbit anti- 
Po  (D.  R.  Colman,  Columbia  University,  New  York) (1:200);  afffinity- 
purified 192-IgG mAb against rat nerve growth factor receptor which also 
recognizes the Ran-I antigen (Yan and Johnson, 1988; Jessen et al.,  1990) 
(E.  M.  Johnson, Washington  University School of Medicine,  St.  Louis, 
MO) (1:100); 01 which is specific for galactocerehroside (GalC) (Bansal et 
al., 1989) and 04 mAbs (L Sommer, Southern General Hospital, Glasgow) 
(1:20 and 1:10, respectively);  a mAb raised against GaIC that we hereafter 
refer to as R-mAb whose specificity  also overlaps  with that of 04 (13. 
Ranscht, Cancer Research Centre, La Jolla, CA) (1:t00). The following an- 
tibodies were purchased: NF.-L, NF-M, and NF-H mAbs (Sigma Chemical 
Co.) were each used at a dilution of 1:200; NF-M mAb (Biomakor,  Israel) 
was  used  at  1:20;  NF-L  (Boehringer  Mannheim Biocbemicals,  Indi- 
anapoiis,  IN)  was  used  at  1:100; GFAP mAbs from Amersham Corp. 
(Arlington Heights,  IL) and Boehringer Mannheim Biochemicals (clone 
G-A-5), were both used at 1:5; rabbit anti-GFAPs were either from Dako- 
patts (Copanh~gen) or were a gift from E. Sock (University of  Copenhagen) 
and were used at 1:200; vimentin mAh was from Serotec (Kidlington,  Ox- 
ford,  England) and was used at  1:50. An anti-p145  rabbit antibody was 
raised against a  detergent-insoluble fraction of rat CNS myelin,  affinity 
purified by chromatography on a column ofp145 coupled to CNBr-activated 
Sepharose (Sigma Chemical Co.) and was used at 1:5. The p145 ligand was 
purified by electroelution  from polyacrylamide gels after SDS-PAGE of 
PNS myelin (Hunkapiller et al., 1984). The afffinity-purified p145 antibody 
was used at 1:5. A rabbit antibody that recognizes NF-L, NF-M, and NF-H 
was a gift from D. DaM (Harvard University Medical  School). 
lmmunoprecipitation 
Schwann cells from the sciatic nerves of 5-d-old rat pups were grown for 
24 h in Optimem containing 10% FCS, rinsed four times in Optimem, and 
labeled in Optimem comaining 10  4  M db-cAMP and [3SS]methionine (1 
mei/ml) (ICN Biocbemicals,  Buckinghamshire, England) for 24 h at 37~ 
After labeling, ceils were rinsed extensively  with Optimem before extrac- 
tion with the buffer containing Triton X-100. Cytoslmleton  fractions were 
solubilized in 2% SDS with 1 mM DTT and then diluted with 4 vol of solu- 
tion A (50 mM Tris-HCl, pH 7.4, 2.5%  [vol/vol] Triton X-100, 150 mM 
NaCl, 4 mM EDTA containing 1 mM Na-p-Tosyl-L-lysine chloromethyl ke- 
tone [Sigma  Chemical Co.],  and  10/~g/mi leupeptin [Sigma  Chemical 
Co.]).  The solubilized samples were preeleared  with protein A  agarose 
(Sigma Chemical Co.) in solution A. Each sample containing 0,8  x  106 of 
TCA-precipitable  r  was incubated with a  nonimmune serum (2  tzl), 
affinity-purified p145 antibody (150 tzl), or rabbit antibovine  vimentin (2 t~l) 
for 90 min at room temperature followed by protein A agarose for 60 rain. 
Immune complexes were centrifuged  at 13,000 g for 5 min and washed six 
times with solution A containing  0.1% SDS and finally with solution A with- 
out detergents. The samples were solubilized and electrophoresed  on 5-17 % 
gradient polyacrylamide gels using the buffer system of Laemmli (1970). 
Gels wet, stained with 0.2%  PAGE Blue g3 (BDH), destained, incubated 
for 30 min in Amplify (Anmrsham Corp., Buckinghamshire, England), and 
dried. The dried gel was exposed to X-ray film (Konica,  Stifling, Scotland) 
at  -70~  and the autoradiograph was developed  using Kodak X-ray de- 
veloper and fixer solutions. 
Western Blot Analysis 
Cytosketeton pellets and soluble fractions were electrophoresed  on 5-17 % 
gradient polyacrylamide  gels using the buffer system of Laemmli (1970). 
The separated proteins were then electro-transferred  to nitrocellulose  ac- 
cording to the naethod of Towbin et al.  (1979).  The nitrocellulose was 
blocked by incubation for 3 h with 0.2% (wt/vol) gelatin in PBS containing 
0.1% (vol/vol) Triton X-100. Proteins were detected by incubation with ap- 
propriately dilated primary antibodies in blocking buffer followed by goat 
anti-rabbit IgG-HRP conjugate (North East Biochemicals,  Uxbridge,  En- 
gland).  After washing three times with blocking buffer and once with PBS, 
immunoreactive proteins were  detected  using 3,3'-DAB  HCl  and H202 
(Sigma Chemical Co.) as substrates in 50 mM Tris-HC1, pH 7.4. The perox- 
idase reaction was terminated with 2% SDS. 
Indirect Immunofluorescence 
When used on living cells, antibodies  were diluted in PBS containing 2 % 
goat serum (Scottish Antibody Production Unit,  Carluke,  Lanarkshire, 
Scotland) before fixation. Otherwise, cells were first fixed in 3.7% (wt/vol) 
paraformaldehyde (Taab) and quenched with 0.1 M glycine in PBS. To de- 
tect intracellular antigens,  fixed cells were permeabilized with 0.1% (vol/ 
vol) Triton X-100 in PgS for 5 min. For GFAP immunocytochemistry,  cells 
were fixed in ethauol-acetic acid (95:5) for 10 min at -20~  Fixed ceils 
were blocked with 0.2 % (wt/vol) gelatin in PBS. Appropriately diluted anti- 
bodies in PgS/gelatin were incubated for 60 rain with permeabilized cells 
and fixed cyto,  keletons.  The cells were washed and then stained for 30 rain 
with fluorescein-labeled  anti-mouse and rhodamirm-labeled  anti-rabbit Ig 
(North East Biochemical  Laboratories, Uxbridge, England) each diluted 
50-fold with blocking buffer containing 10% goat serum. Coverslips were 
washed several times with blocking buffer and finally with PBS and then 
mounted on glass slides  using 90 (vol/vol) glycerol,  10% (vol/vol) PBS, 
0.1% (wt/vol) 1,4-pbenylenediaminc  (Aldrich Chemical Company, Dorset, 
England). Fluorescence was viewed using 40x or 63 x objectives on a Zeiss 
microscope equipped with phase-contrast and epifluorescence  optics.  Ko- 
dak T-Max (400 ASA) film was used for all photomicrography.  All quoted 
errors in cell counts are SEMs. 
Electron Microscopy 
Schwann cells cultured on aclar discs (Allied Chem. Corp., Waltham, MA) 
were extracted  to yield cytoskeletons  which were then fixed for 30 min in 
4% paraformaldehyde  in 0.1 M phosphate buffer, pH 7.4. After quenching 
in  100  mM  ammonium  chloride,  nonspecific  protein binding sites on 
cytosketetons were blocked with 0.3%  (wt/vol) BSA, 0.5 % (vol/vol) fish 
Kelly et al. Schwann Cells and NF-M  401 Figure 6. Double-label immunofluorescence of cells with anti-p145 and NF mABS. Cells were viewed with rhodamine optics to visualize 
p145 (A-C) and fluorescein optics to visualize NF-L (D), NF-M (E), and NF-H (F). Only NF-M mAb stained Schwarm cells and colocal- 
ized with p145  (B and E).  Bar,  20 #m. 
gelatin (Sigma Chemical  Co.), in 20 mM Tris containing 200 mM NaCl, 
pH 7.4, Primary antibodies were diluted with blocking buffer and incubated 
for 2 h with cytoskeletons in a humid chamber at room temperature.  After 
washing with blocking buffer, incubations with gold-labeled secondary anti- 
bodies were carried out at room temperature for 2 h in a humid chamber. 
The goat anti-rabbit IgG-10-nm gold (Janssen,  Olen, Belgium)  and 5-nm 
gold-labeled goat anti-mouse IgG +  1 gM (H +  L) (Amersham Corp.) an- 
tibodies were  each diluted  20-fold  in blocking buffer.  After  washes  in 
Tris/NaC1 and 0.1 M sodium cacodylate buffer, pH 7.4, samples were fixed 
in 2.5 % glutaraldehyde  in 0.1 M sodium cacodylate for 30 min at room tem- 
perature and left overnight in the same buffer. Samples were postfixexl with 
1% OsO4 in 1% potassium ferrocyanide in 0.1 M sodium caeodylate for 60 
min at 4~  and then dehydrated  in a graded ethanol series:  50%-5 min, 
70%-5 min, 90%-5 min, absolute-10  rain (twice), absolute-5  rain. The 
infiltration protocol was Epon (Taab)-ethanol (1:1) for 1 h at room tempera- 
ture, Epon, two changes during the next  12 h followed by embedding in 
fresh Epon and polymerization at 60~  for 12-24 h. Pale-gold  sections 
were cut on an LKB III ultra microtome and sections were viewed on a Jeot 
100 CX transmission electron microscope. 
Isolation and Characterization  of  cDNA clones from 
Rat Sciatic Nerve and Schwann Cell cDNA Libraries 
Total  RNA was  extracted from PI0 rat sciatic  nerve and from cAMP- 
induced P4 rat Schwann cells with RNazol B (Biogenesis,  Bournemouth, 
England) following the manufacturer's instructions, following which poly- 
(A)  + RNA  was  isolated  (Aviv  and Leder,  1972).  For the sciatic nerve 
eDNA library, first and second strand synthesis was carded out by standard 
methods (Maniatis et al.,  1989).  After size fraetionation on a Sepharose 
CL-4B  (Pharmacia  Fine  Chemicals,  Piscataway,  NJ)  column,  EcoRI- 
linkered eDNA was ligated to ~,gtll  arms (Promega Biotec, Madison, WI) 
and packaged using Gigapack Gold (Stratagene,  Cambridge, England). The 
Schwann cell library was constructed unidirectionally in SalI/NotI double- 
digested  hgt22A (Gibeo BRL) following the manufacturer's  instructions. 
Affinity-purified  anti-p145 antibodies were used to screen 5.0  x  10  ~ and 
2.5  x  105 recombinants in the sciatic  nerve and Schwann cell libraries, 
respectively (Young and Davis, 1983), and positive clones were identified 
using a goat antirabbit antibody conjugated to HRP (North East Laborato- 
ries). ~,DNA was isolated from plaque-purified  clones (Lockett, 1990) and 
the excised eDNA inserts were subeloned into pIBl30 0BI) or pSPORT  1 
(Gibeo BRL) for further analysis. 
Subeloned eDNA inserts (1 rig) or the eDNA products from reverse tran- 
scribing total RNA (5 t~g) from cAMP-induced  P4 rat Schwann cells using 
oligo(dT) as primer (Doberty et al., 1989) were amplified by PCR with NF- 
M-specific primers. Each reaction was subjected to 30 cycles of amplifica- 
tion with 2.5 U Ampli-Taq in a total volume of 100 td of a buffer supplied 
by the manufacturer (Perkin-Elmer  Cetus, Norwalk, CT). The primers used 
for amplification  spanned a  1,234-bp  segment of the NF-M sequence be- 
tween bases 1288 and 2522 using the numbering system of Napolitano et 
al. (1987). 
Restriction endonuelease fragments directionally subcloned into M13 
mpl8 and mpl9 vectors (New England Biolabs, CP Laboratories, Hertford- 
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rat brain  (B), P4 Schwann cells that 
had been induced with db-cAMP (SC) 
and P3 sciatic nerve (SN). RNA (5, 5, 
and  15 /zg, respectively) was electro- 
phoresed on a 1.2 % formaldehyde aga- 
rose gel and transferred to Hybond N 
membrane.  The  filters  were  probed 
with a Bst EII/DraI fragment of the I1 
cDNA that was 32p labeled by random 
priming.  The  autoradiograph  shows 
that the probe recognized a mRNA of 
"~ 3 kb in B, SC, and SN thereby sup- 
porting the identity of p145 with NF-M, 
shire, England) and unidirectional deletions (Henikoff, 1984)  prepared in 
the Phagescript vector (Stratagene) were sequenced by the dideoxy chain 
termination technique (Sanger et al., 1977) using Sequenase (United States 
Biochemical Corp., Cleveland, OH). 
Fusion Protein and Antifusion Protein Antibodies 
E. coli (strain C600) was infected with either hgtl 1 or a recombinant hgtl 1 
containing a p145 clone pSNP1011 isolated from the sciatic nerve cDNA li- 
brary, whose sequence was identical to that of rat NF-M between nucleo- 
tides 2137 and 2545, numbered according to Napolitano et al. (1987).  The 
fusion protein was isolated by preparative SDS-gel electrophoresis  ofE. coli 
lysates and an antiserum (AI1) was produced in rabbits. Lysates from cells 
infected with either nonrecombinant 3,gtl 1 or recombinant hgtl 1 containing 
the  pSNP10II  clone  were  electrophoretically  resolved,  transferred  to 
nitrocellulose, and immunoblotted with All and afffinity-purified anti-p145 
at dilutions of 1:1,000 and  1:50, respectively. 
Northern Blot Analysis 
Total RNA (5-15/zg) from rat sciatic nerve, cAMP-induced Schwann ceils, 
and brain was electrophoresed  on 1.2 % formaldehyde  agarose gels (Kroczek 
and Siebert,  1990)  and transferred to Hybond N  membrane (Amersham 
Corp.) by vacuum blotting in 20  x  SSC. The filters were probed for 2 h 
in  QuickHyb  solution (Stratagene)  with a  BstEII/DraI  fragment of the 
pSNP1011  clone that was  32p-labeled  by  random priming (Feinherg and 
Vogelstein, 1983) and they were washed to a final stringency of 0.2  x  SSC 
at 65~ 
Results 
p145 Is a $chwann Cell Cytoskeleton Protein 
Schwann cells were isolated from the sciatic nerves of 5-d- 
old rat pups and cultured for 24 h  in Optimem containing 
10%  FCS.  Cells  were  then  extracted  with  an  extraction 
buffer containing Triton X-100 (Wilson and Brophy, 1989); 
the resultant cytoskeleton and soluble fractions were electro- 
phoresed on  SDS-PAGE and  the  separated  proteins  were 
analyzed by Western blotting. Immunoblotting with affinity- 
purified  anti-p145  and  rabbit  antivimentin  demonstrated 
that, like vimentin, all of the p145 remains associated with 
the cytoskeleton fraction and that the anti-p145 specifically 
recognizes only p145  in  Schwann  cell  cytoskeletons;  the 
vimentin antibody was similarly specific (Fig.  1). The pres- 
ence of p145 in Schwann cell cytoskeletons was also demon- 
strated by indirect immunofluorescence (Fig. 2). 
p145 Is an IF Protein 
The Schwann cell cultures used in some of these experiments 
also contained fibroblasts. Schwann cells were identifed by 
the phenotype S100  §  Thy 1-, fibroblasts by the phenotype 
S100-, Thy 1  §  and expressors of p145 were always Thy 1-. 
The  staining  pattern  of p145  by  immunofluorescence  in 
Schwann  cells was  intracellular and  filamentous and  was 
very similar to that observed for vimentin (Fig. 3, B and C). 
It has  long been  recognized that  when cultured cells are 
treated with cytoskeleton-disrupting drugs such as colchi- 
cine, the classic response of IF proteins is to retract from the 
cell periphery and reorganize around the nucleus (Yang et 
al., 1985). This perinuclear bundling oflFs was observed for 
both p145 and vimentin in response to colchicine treatment 
(Fig. 3, E and F). When colchicine-treated cultures were al- 
lowed to recover in medium without colchicine for a further 
24 h, both p145 and vimentin expression reverted to the nor- 
mal staining pattern (data not shown). The cytoskeleton as- 
sociation and response of p145 to colchicine treatment indi- 
cated that this protein may be part of the IF network. Further 
proof for this hypothesis was  provided by immunoelectron 
microscopy. Schwann cell cytoskeletons were prepared and 
double labeled with anti-p145 and vimentin mAb followed by 
gold-conjugated anti-rabbit IgG and  anti-mouse IgG sec- 
ondary  antibodies  (10  and  5  nm,  respectively).  The  two 
different sized gold particles decorated the same 10-nm fila- 
ments indicating that p145  is  a component of IFs and that 
p145 and vimentin reside on the same IFs (Fig. 4 A).  The 
coresidence of p145 and vimentin is more clearly visible at 
higher magnification (Fig.  4 B).  In addition to containing 
IFs composed of both p145  and vimentin,  some  Schwann 
cells contained only vimentin IFs and these were not labeled 
with p145  (Fig. 4  C). 
cDNAs from Sciatic Nerve and Schwann Cell Libraries 
Show p145 Is Identical to NF-M 
We have provided evidence that  p145  is  an  IF protein of 
Schwann  cells;  clearly the  relationship  of this  protein to 
other well-characterized IF proteins is an important ques- 
tion. To establish the identity of p145, a partial cDNA clone, 
pSNP1011, was isolated by immune-screening a sciatic nerve 
cDNA library with anti-p145 and was found to include the 
sequence between bp  2137-2545  of the rat neurofilament 
protein NF-M cDNA (Napolitano et al., 1987). An antibody 
(AI1) raised against the ~-galactosidase fusion protein prod- 
uct of this clone recognized p145 thus establishing the rela- 
tionship  between p145,  pSNP1011,  and  NF-M  (Fig.  5  a). 
Western blotting showed that both AI1 and a polyclonal anti- 
body that recognizes the NF triplet NF-L, NF-M, and NF-H 
cross-reacted with Schwann cell p145 (Fig. 5 b). The absence 
of NF-L and NF-H from Schwann cells was confirmed by im- 
munofluorescence microscopy  (Fig.  6).  The  NF-M  mAb 
stained Schwann cells in an identical fashion to p145 anti- 
body  thus  supporting  the  relatedness  of p145  and  NF-M 
(Fig.  6). 
Further support for the identity of p145 with NF-M came 
from Northern blotting in which a mRNA of the same size 
(~3,000 nucleotides) as that of brain NF-M was detected in 
sciatic nerve and  Schwann cells using pSNP1011  as probe 
(Fig.  7). 
To establish  the precise relationship between p145  and 
NF-M  we  prepared a  cDNA library from cAMP-induced 
Schwann cells,  screened it with anti-p145 and isolated 24 
positive clones. Seven clones were amplified by PCR with 
primers that span bp 1288-1310 and 2505-2522 of the NF-M 
Kelly et al.  Schwann  Cells and NF-M  403 M  S  Y  T  L  D  S  h  G  g  P  S  A  Y  R  R  V~T  E  T~S  S  F  S 
1  GACC~GCCACACACC(  CAAG~GATG  AGCTACAC  GCT  GGACTCGCTGGGCAACCCGTCCGCCT  ACCGGC  GC  ~  ~C  C  ~  A~GT  III 
R  V  S  G  S  P  S  S  G  F  R  S  Q  S  W  S  R  G  S  P  S  T  V  S  S  S  Y  K  R  S  A  L  A  P  R  L  A 
112  CGTGTGA  GCGGTTC  CCCGTC  CAGCGGCTT~GCAGTCCTGGTC~GG~  GCCCAG~CCGTgTCCTCCTCCTACAA~  ~  ~C  ~  ~C  222 
Y  S  S  A  M  h  S  S  A  E  S  S  L  D  F  S  Q  S  S  S  L  L  N  G  G  S  G  G  D  Y  K  h  S  R  S  N  g 
223  TACAGCTCGGCT  ATGCTCAGCTCG~  C  GAGAGCAGCCTC  GACTT  CAGCCAGTCCTC~ GCTGC'~AACGGC~~ A~G~CC  ~C~G  333 
K  E  Q  L  Q  G  L  N  D  R  W  A  G  Y  I  R  K  V  H  Y  L  E  Q  Q  N  K  E  I  E  A  E  I  H  A  L  R  Q 
334  AAAGAGCAt3CTGCAGGGGCTGAACGACC  GTTTCGCCGGCTACATCGAGAAAGTGCACTAC~CAACA~A~TC  ~  GA~C~ ~G  444 
K  Q  A  S  H  A  Q  L  G  D  A  Y  D  Q  E  I  R  S  L  R  A  T  L  g  M  V  N  a  B  K  k  Q  V  Q  L  D  8 
445  AAC,  CAC~ CT  CGCACGCC  C  AGCTGGGTGACC,  C~ ACGACCAC,  GAGATCCGA  GAGCTGC  GCGCCA~T~C~~  ~~  555 
P  H  L  E  E  D  I  H  R  L  K  E  R  g  E  E  l~  A  R  L  R  D  D  T  g  A  A  I  R  A  (~)  R  K  D  I  E  E 
556  GATCACTTGGAGGAA  GACA  TCCAC  CC,~GGAGCC~  GAGGAGGAGG~GGCTGL~CGACA~  ~~~~TA~G  666 
S  S  M  V  K  V  E  L  P  K  K  V  0  S  L  Q  D  B  V  k  P  L  R  S  N  H  8  E  E  V  k  P  L  L  k  Q  ! 
667  TCGTCGATGGTTAAGGTC~GCTGGACAAGAAGGTGCAGTC~GCAGGATGAGGTGG~CTGC~C  ~~ ~AC~  ~  ~  777 
Q  A  S  a  I  T  V  E  R  K  D  Y  L  K  T  D  I  S  T  A  L  g  E  I  R  S  Q  L  E  C  H  S  D  Q  N  M  H 
778  CAGGCGTCGCACATCACCGTAGAGt~GACTACCTGAAGACAGACATCTCCACGGCGCTGAAAGAGA~~C  A~  C  ~G~C  888 
Q  A  E  E  W  F  K  C  R  Y  A  K  L  T  E  k  A  E  Q  N  g  g  A  I  R  8  A  K  E  E  I  A  E  Y  R  R  Q 
889  CAGGCCGAAGAGTC,  GTTCAAATC,  CCGCTAC  G~GCTCACCGAGGCGGCCGAGCAGAACAAGGAGGCCA~~~GAT~CC  ~A~G  999 
L  Q  S  K  S  I  E  L  R  S  V  R  G  T  K  E  S  L  E  R  Q  L  S  D  I  E  E  R  H  N  H  D  L  S  S  u  Q 
1000  ~C~G'TCCAAGAt~TTGAGC~GAGT~GAGGCACTAAGGAGTCC  CTC~CGGCAC~A  CAT  C~  ~ ~C  ~  CC  AC  ~AC~G  1110 
D  T  I  Q  Q  L  E  N  E  L  R  G  T  K  W  E  M  A  R  H  L  R  8  Y  Q  D  L  L  N  V  K  M  A  L  D  I  E 
1111  GACACCATCCAGCAGC~TGAGCTTCGG~CAAAGTGGGAAATGGCTCGTCAT~GCGA~TAC~~C  ~  T~~G  1221 
I  A  A  Y  R  K  L  L  E  G  E  B  T  R  F  S  T  F  S  G  S  I  T  G  P  L  Y  T  H  R  Q  P  S  V  T  I  S 
1222  ATCC,  CC  GCAT~  TAGGAAACT  ACTGGAGGGT~GAGACCAGATTTAGCACA  TTTTCAGGAAGCATCA  ACACACAC  CGACAGCC~A~TA~C  1332 
S  K  I  Q  K  T  K  V  E  A  P  K  L  K  V  Q  H  K  F  V  E  E  I  I  E  E  T  K  V  E  D  E  K  S  E  M  E 
1333  AGT  AAGAT~AGAAGACCA~GTCGAC,  C~GCTCAAGGTCCAACACAAATT~C~TT~~  ~GA~  AG~GT~T~  1443 
D  A  L  T  V  I  A  E  E  L  A  A  S  A  K  E  E  K  E  E  A  E  E  K  E  E  R  P  E  V  E  K  S  P  V  K  S 
1444  GAC  C'CCcTCACAGTCATTC~GAGGAATTC~GCCTCTGCCAAAGAC'GAGAAAGAAGAGGCAGAAGAAAA~~C~G~~~  1554 
P  E  A  K  E  E  E  E  G  E  K  E  E  E  E  E  G  Q  g  E  g  g  E  8  D  E  G  V  K  S  D  Q  A  E  R  G  G 
1555  CCTGAC~AAGGAAGAGC~GGAAGG~GGAGG~GAAGAGGAAGGCCAA~~~~~~~A  1665 
S  E  K  E  G  S  S  E  K  D  E  G  E  Q  E  E  E  G  E  T  E  A  E  G  E  G  E  E  A  E  A  K  E  E  K  K  T 
1666  TCTGAGAAGGAA(~CC~GTGA~GGATC,  AAGG~GC~GAAGAAC, AAGGG~CTGA~~~~~~  1776 
E  G  K  V  E  E  M  A  I  K  E  B  I  K  V  E  K  P  B  K  A  K  S  P  V  P  K  S  P  V  E  E  V  K  P  K  P 
1777  GAC~GGTCGAGGAAATGGCTATC~GGAAATCAAGGTCGAGAAGCCCGAGAAAGCCAAGTCCCCTGTC~A~C  ~~ ~~A  1887 
E  A  K  A  G  K  D  E  Q  K  E  E  E  K  V  E  E  K  K  E  V  A  K  E  S  P  K  E  E  K  V  E  K  K  E  E  K 
1888  GAA(~AAAC.~CCGGA~C~ATGAC~:AGAAGGAGGAAC~GA~GTT~GGAGAAGAA~A~~~G  ~  ~A~~A~G  1998 
9  K  D  V  P  D  K  K  K  A  E  S  P  V  K  E  K  A  V  E  E  M  I  T  I  T  K  8  V  K  V  S  L  B  K  D  T 
1999  CC~GATGTCCCAGAT  AA~GAAC~G~CC  CCA~AAAAGC~GTAGAGGAAATGA~C~A  ~~~  ~CC  2109 
K  E  E  K  P  Q  Q  Q  E  K  V  K  E  K  A  E  E  E  G  G  S  E  E  E  V  G  D  K  S  P  Q  E  S  K  K  E  D 
2110  AAA  C~GGAGAAC~GCAGCAGGAGA~GGAGAAGGCAGAGGAGGAC~A~A~~C~G~~C  2220 
I  A  I  N  G  E  V  E  G  K  E  E  E  E  Q  E  T  Q  E  K  G  S  G  Q  E  E  E  K  G  V  V  T  N  G  L  D  V 
2221  ATAGCTATCAATGGGGAGGTGGAAGGAAAAGAGG  AGGAGGAGCAGGAAACTCAGGAGAAGGGCAGTGGGCAA~~~~~  2331 
S  P  A  E  E  K  K  G  B  D  R  S  D  D  K  V  V  V  T  K  K  V  8  K  I  T  S  E  G  G  D  G  A  T  K  Y  I 
2332  AGCCCTGCGGAGGAAAAGAAAC,  GGGAGGATAGAAGTC,  ATGACAAAGTC~GGTC,  ACCAAGAAC-GTAGAAAAAA~  ~  GA  ~A~TA~TC  2442 
T  K  S  V  T  V  T  Q  K  V  E  E  H  E  E  T  F  E  E  K  L  V  S  T  K  K  V  E  K  V  T  S  H  A  I  V  K 
2443  ACCAAATCTGTTACT  GTCACTCAAAAGGTTGAAGAGCATGAGGAGACC'FI"TGAGGAC,  AAGCTGGTGTCAACT~AG~A~~T~G  2553 
E  V  T  Q  G  D 
2554  GAA~[~ CCCAGGGTGACTAAGATC~GTCCATTGCA~C~AAC,  CCATACAACAAT~  ~T~GA~ ~C~G~~A  2664 
2665  GGG~  CAGACATTGT  AT~CT~  G~TATGAGC,  G  AACTGCATGCAAGCTCAGC~  C~~~~T~A~  A~AT~  A  2775 
2776  CCTAGC~AAT~GCCAGT~CCTAAC~GTTC.AAA  GAC~ACTCC~AT  GTCTTCAGA  T~T  ATTACG~  ~AC~A  ~T~T  ~CAGA  2886 
2887  AC~AGC  CTTAAGA~GCTATAT  ATGAATA  CTTAT  G~  ACC~CACT  C~C~ATTT  AAAATGGACTTCA~T~A~  C~  G~  AC~ACA~  ~  2997 
2998  CCTTAT  q'TTGATTG  ATGTTAAA  TGTCACAC,  CAGTTCTTC/2TCAATAAAGGTCATACTGC,  AACCATAAA~AAAA~  3078 
Figure 8. The complete nucleotide and deduced amino sequence of the Schwann cell NF-M clone pISCP4NFM.  Symbols represent points 
of difference  from Me sequence of lat brain NF-M (pNF-M2D)  as published by Napolitano et al. (1987).  Underlined sequences denote 
additional b~ses  in pISCP4NFM which are not present in pNF-M2D.  Single base differences  are indicated by the triangles and encircled 
amino acigs denote changes in the amino acid sequence as a result of single base changes. The star between the valine and threonine denotes 
tl:e position of a codon in brain NF-M that encodes proline which is ab,~ent from Schwann cell NF-M.  This sequence is available from 
EMBL/GenBanldDDBJ  under accession number Z12152. 
The Journal of Cell Biology, Volume 118,  1992  404 Figure 9.  Double-label immunofluorescence localization of NF-M with markers of Schwann cell differentiation. Cells were isolated from 
1-d  rat  sciatic  nerve and cultured  for  16 h.  Visualization of NF-M  (B,  D,  and F)  was  by rhodamine optics and NGFR  (A),  04  (C), 
and GalC  (E) by fluorescein optics.  All NF-M  + cells were  NGFR  + and 04  +.  In contrast,  three phenotypes were detected in E  and F: 
GalC+,NF-M + (large arrows);  GalC+,NF-M -  (small arrows);  GalC-,  NF-M  § (arrowheads).  Bar, 20 #m. 
Kelly et al. Schwann Cells and NF-M  405 Figure 10. Histogram showing the percentage of Schwarm  cells ex- 
pressing 04, GalC, and NF-M at ages El8, P1, and P4. Schwann 
ceils were isolated from sciatic nerves and kept in culture for 16 h 
before processing for indirect immunofluorescence. The number of 
Schwann ceils as determined by S100 immunoreactivity was: 87 + 
1% at El8, 86 +  2% at P1, and 72 +  2% at P4. The increase in 
the number of GalC  + cells from El8 to P4 reflects the differen- 
tiation of myelin-forming cells.  At P4, 88%  of GalC  + cells ex- 
pressed NF-M which shows that NF-M  is expressed by myelin- 
forming cells. 
sequence (Napolitano et al.,  1987)  and each yielded the 
predicted 1233-bp fragment, as did direct reverse transcrip- 
tion-PCR amplification of total Schwann cell RNA (data not 
shown).  The longest of these clones, plSCP4E3, was fully 
sequenced and corresponded to the sequence of  NF-M (pNF- 
M2D)  published  by  Napolitano  et  al.  (1987)  from  bp 
550-2717 together with a further 332 bp at the 3' end to the 
poly A tail. To complete the sequence at the 5' end an over- 
lapping clone plSCP4B8 of 1693 bp was sequenced. The two 
overlapping clones constituted pISCP4NFM and contained 
the entire coding region for NF-M with additional sequence 
at both the 5' and 3' ends. The full-length clone pISCP4NFM 
was obtained by ligating the SalI/SacI fragment (5' end) of 
plSCP4B8 to the SacI/NotI fragment (3' end) of pISCP4E3. 
The resulting construct was subcloned into pSPORT 1 for 
further analysis. The relationship between the Schwann cell 
NF-M and that isolated from brain (Napolitano et al., 1987) 
is shown in Fig.  8. 
Developmental Expression of NF-M in Schwann Cells 
The relationship between NF-M  expression and  Schwann 
cell development was investigated by comparing the expres- 
sion of NF-M with that of the well-characterized differentia- 
tion markers: Rand (217c) which is present in most Schwann 
cells at El8, 04 which appears at El6, and GalC which is 
first detectable in myelin-forming Schwann cells at E18-19 
(Jessen et al., 1990; Mirsky et al., 1990). Since myelination 
begins in earnest soon after birth (Hahn et al.,  1987), we 
considered that cells taken from the sciatic nerves of 1-d-old 
rat pups should contain a significant number of premyelinat- 
ing and early myelin-forming cells together with a number 
of non-myelin-forming cells.  The cells were cultured  for 
16 h, and the expression of NGFR, NF-M, 04,  and GalC 
was determined by indirect immunofluorescence. During this 
period of culture there was no significant dedifferentiation of 
phenotype as a result of the loss of axonal contact since 31% 
of the Schwann cells were still strongly Po positive. 
All of the Schwann cells from 1-d sciatic nerve expressed 
NGFR  whereas  much  fewer  NF-M  + ceils  were  present 
(Fig.  9,  A  and  B).  Cells  that  were  NGFR+,NF-M  -  and 
NGFR+,NF-M  + were observed but there were no NGFR-, 
NF-M  + ceils which indicated that NGFR expression pre- 
cedes that of NF-M. Similarly, 04 expression precedes that 
of NF-M (Fig. 9, C and D). In contrast, cells stained with 
the OI mAb which specifically recognizes GalC displayed 
three phenotypes: GalC-,NF-M  +, GalC+,NF-M  +, and a rel- 
atively small number of GalC+,NF-M  -  (Fig.  9, E  and F). 
These results suggested that NF-M appears during Schwann 
cell development in the rat sciatic nerve after 04 but some- 
what earlier than GalC. 
To elucidate the time of  NF-M appearance during develop- 
ment, and the relationship between NF-M expression and 
myelination, Schwann cells were isolated from sciatic nerves 
at El8, and from nerves at P1 and P4. After 16 h in culture, 
the cells were double labeled for NF-M and GalC and for 
NF-M and 04 (Fig. 10). The percentage of cells in these cul- 
tures that were Schwann cells was determined by measuring 
the number of S100  + cells in parallel cultures (87  +  1% at 
El8,  86  +  2%  at P1, and 72  +  2%  at P4).  At each age, 
cells had been in culture for 16 h before processing for in- 
direct immunofluorescence. 04  expression,  which  is  first 
detected in Schwann cells at El6,  increased from 69%  of 
Schwann ceils on El8 to 96% of Schwarm cells on P4 (Fig. 
10). This trend was consistent with the increased expression 
on Schwann ceils of 04 with age observed by Jessen and 
Mirsky  (1991).  The number of Schwann ceils expressing 
NF-M also showed an increase with age from 29% on El8 
to 58% on P4. Our results on GalC expression are difficult 
to compare with others' work as we used the O1  antibody 
which is more specific for GalC (Bansal et al.,  1990) than 
is the R-mAb antibody used in other studies (Mirsky et al., 
1990). The percentage of Schwann cells expressing GalC in- 
creased from 9% on El8, through 14% on P1 to 36% on P4. 
At  P4,  three  GalC,  NF-M  phenotypes  were  observed: 
GalC+,NF-M  + (50  +  3%), GalC+,NF-M  -  (7  5-  2%), and 
GalC-,NF-M  + (43  5-  4%).  Thus,  88%  of the GalC  + ceils 
expressed NF-M, which indicates that NF-M is present in 
myelin-forming Schwann cells.  Myelin synthesis begins in 
earnest on P1 and we found the expected rise in Po expres- 
sion by Schwann cells from 31% on P1 to 56% on P4. Our 
values for the observed expression of Po on P1 and P4 par- 
alleled those for NF-M and support our argument that NF-M 
is a component of myelin-forming Schwann cells. 
Figure 11. Double-label immunofluorescence showing  the induction by cAMP analogues of NF-M and GalC in Schwann cells. Schwann 
cells were isolated from 5-d rat sciatic nerves and cultured for 24 h in Optimem and 10% FCS. They were then cultured for a further 
48 h in: (A-C)  10% FCS, (D-F)  10% FCS and 10 ~M db-cAMP; (G-I),  10 ~M db-cAMP without FCS. The NF-M was visualized by 
rhodamine optics ((7, F, I) and GalC by fluorescein optics (B, E, H). Cells were also visualized by phase contrast optics (A, D, G). Elevated 
cAMP induces NF-M (F and I) but Gale expression also requires serum deprivation (H). Bar, 20 ~m. 
The Journal of Cell Biology.  Volume 118, 1992  406 Kelly et al. Schwann Cells and NF-M  407 Figure 12. Indirect immunofluorescence of NF-M and Po in Schwann cells after treatment with db-cAMP. Schwann cells from 5-d rat sci- 
atic nerve were treated with cAMP analogues for 3 d as in Materials and Methods. Cultures were viewed with rhodamine optics to visualize 
NF-M and fluorescein optics to visualize Po. Bar, 10/~m. 
Induction of  NF-M in Schwann Cells by 
cAMP Analogues 
Schwann cells were isolated from sciatic nerves of rats at P5 
and grown in Optimem 1 containing 10% FCS for 24 h be- 
fore treatments with db-cAMP. When cells were kept for a 
further  48  h  in  Optimem  containing  10%  FCS,  they 
dedifferentiated and very few cells expressed NF-M or were 
stained with R-mAB which recognizes GalC and the 04 an- 
tigen (Fig.  11, B and C).  However, if after the initial 24 h 
of culture cells were kept for 48 h in Optimem containing 
10% FCS and db-cAMP, the loss of expression of NF-M was 
prevented (Fig.  11 F) which suggests that NF-M expression 
in Schwarm  cells is under axonal regulation because eleva- 
tion of intracellular cAMP levels is believed to mimic the 
effects of axons  on  Schwann  cells  (Sobue  and  Pleasure, 
1984a,  1986; Porter et al.,  1986). 
The change in Schwann cell morphology induced by db- 
cAMP (Fig.  11 E) is well documented (Sobue et al.,  1986; 
Morgan et al., 1991). If serum were removed after the initial 
Figure 13.  Immunoprecipita- 
tion of NF-M from Schwann 
cells. Schwann cells from 5-d 
rat sciatic nerve were meta- 
bolically labeled for 24 h with 
[35S]methionine in  the  pres- 
ence of 5 x  10  -4 M db-cAMP. 
After extraction of the cells, 
the cytoskeletons were solu- 
bilized in SDS and immuno- 
precipitates were analyzed by 
SDS-PAGE. Lane 3 shows a 
protein with an Mr of 145 that 
was immunoprecipitated with 
anti-p145 which was not pres- 
ent  in  immunoprecipitates 
using  using  nonimmune  se- 
rum (lane 1) or antivimentin 
(lane 2). 
24 h in Optimem and 10%  FCS, and the cells were kept for 
a  further 48 h  in Optimem with  db-cAMP,  expression of 
NF-M was induced (Fig.  11 I) and all of the NF-M  § cells 
were R-mAb  § (Fig. I I H). Po induction can only be induced 
by cAMP analogues when Schwann cells are quiescent (Mor- 
gan et al.,  1991), and Fig.  12 shows that these Po  § cells are 
also  NF-M  §  Thus,  NF-M  is  present  in  cells  expressing 
myelin proteins. In parallel experiments designed to map the 
appearance of NF-M expression during Schwarm cell devel- 
opment, we found that 04 and NF-M appear in dividing cells 
and precede the appearance of GalC and Po (Figs. 9 and 10) 
both of which are only expressed in nondividing cells (Mor- 
gan et al., 1991). Thus, the results from tissue culture studies 
were consistent with development in vivo. 
Cultured Schwann cells were metabolically labeled in the 
presence of db-cAMP, and anti-p145 specifically immuno- 
precipitated a  protein of Mr  145  (Fig.  13,  lane 3).  In all 
three lanes,  vimentin and some bands with lower Mr were 
precipitated, even when an irrelevant antibody was used (Fig. 
13, lane/). Antivimentin did not immunoprecipitate NF-M 
(Fig. 13, lane 2) which is consistent with our finding that this 
antibody does not recognize NF-M on a Western blot, nor 
does the anti-p145  recognize vimentin (Fig.  1). The NF-M 
could not be immunoprecipitated from dedifferentiated cells 
(data not shown) which supports our contention that NF-M 
is a protein of differentiating Schwann cells. 
Discussion 
In this paper we have described a component of the IF net- 
work  of differentiating  Schwann  cells  which  we  initially 
called p145 and subsequently identified as NF-M. We have 
identified p145 as an IF protein because it is exclusively  pres- 
ent in the cytoskeleton, it bundles perinuclearly in response 
to colchicine, and because it can be detected by immunoelec- 
tron microscopy in IFs. Axonal contact appears to regulate 
NF-M  expression  because  it  is  lost  from  dissociated 
Schwann cells in tissue culture and because cAMP, which is 
believed to mimic some of the effects of axons on Schwann 
cells, induces re-expression of the protein. 
The Journal of Cell Biology,  Volume  118, 1992  408 In the rat sciatic nerve, the first Schwann cells appear at 
E15-16  (Jessen  and  Mirsky,  1991);  in  response  to  axon- 
Schwann cell contact they begin to express 04 between El6 
and El7 and by E20 all Schwann cells express 04 (Jessen et 
al., 1990). Consistent with these earlier data we found a high 
number of 04+ cells in our cultures from sciatic nerves at 
El8  (69%),  and  by  P4  essentially  all  Schwann  cells  ex- 
pressed this marker. Myelin-forming cells express GalC at 
E18-19 whereas non-myelin-forming Schwann cells differen- 
tiate  later.  We  found  an  increase  in  the  percentage  of 
Schwann cells expressing GalC from 9% on El8 to 36% on 
P4, a result which is consistent with the increase in abun- 
dance of cells expressing the myelin protein Po during this 
period (31% on P1 and 56% on P4). The percentage of cells 
which  expressed  Po on  P1  and  P4  was  greater  than  that 
which  expressed GalC,  indicating that Po expression pre- 
cedes that of surface GalC. The fact that 88 % of the GalC  § 
cells also expressed NF-M clearly demonstrated that NF-M 
is a protein of myelin-forming Schwann cells. Furthermore, 
we observed that NF-M was retained in Schwann cells that 
were induced to re-express Po (Fig.  12).  Further work will 
be needed in order to delineate the expression of NF-M in 
non-myelin-forming cells. 
The two IF proteins of Schwann cells that have been de- 
scribed so far are vimentin and GFAP.  Vimentin is present 
in  both  differentiated  and  undifferentiated  Schwann  cells 
(Autilio-Gambetti  et  al.,  1982)  and  can  be  detected  in 
Schwann  cell  cultures  from  El5  onwards  (Jessen  et  al., 
1990). GFAP is first detected on El8 but down-regulates as 
the myelinating phenotype develops (Jessen et al.,  1990). 
Therefore, we considered the possibility that NF-M replaced 
GFAP in myelin-forming Schwann cells. We were able to de- 
tect GFAP in a small number of Schwann cells at P4 (5%) 
using the G-A-5 mAb. A much larger number was detectable 
with a polyclonal anti-GFAP from Dakopatts (38 %), which 
is consistent with the data of Jessen et al. (1990). However, 
immunoblotting experiments revealed that the Dakopatts an- 
tibody was not specific for GFAP,  and that it cross-reacted 
with NF-M, a result that is consistent with the findings of 
Hansen et al.  (1989)  who found that this antibody recog- 
nizes neurofilaments. When G-A-5 was used, no difference 
in GFAP immunoreactivity was  observed in cultures from 
1-  and 4-d-old  sciatic  nerves.  Therefore, we  suggest  that 
NF-M and vimentin are the main IF proteins of differentiat- 
ing Schwann cells. There are several precedents for the ex- 
change of IF protein networks during cell differentiation and 
NF-M may replace GFAP at a very early stage of Schwann 
cell development in the sciatic nerve (Lazarides, 1982; Cos- 
sette and Vincent,  1991;  Lendahl et al.,  1990;  Fliegner et 
al.,  1990; Steinert and Liem,  1990). Myelination necessi- 
tates major changes in Schwann cell morphology which must 
involve the cytoskeleton and the NF-M IF protein may be 
best suited to the role of sustaining the altered shape which 
allows axon ensheathment and subsequent myelination. 
This paper is the first report of the normal occurrence of 
an IF protein of the NF type in nonneuronal cells in the ner- 
vous system. Although NF proteins are normally restricted 
to postmitotic neurons, NF-L has been detected in the beta 
cells of the islets of Langerhans in the embryonic rat, thus 
raising the possibility that these cells originate in the neural 
crest (Escurat et al.,  1991). Furthermore, NF proteins have 
been incorporated into IF-like arrays in nonneuronal cells af- 
ter transfection (Monteiro and Cleveland,  1990;  Chin and 
Liem, 1990) and in transgenic mice (Monteiro et al., 1990). 
It has not escaped our attention that the abundance of NFs 
in peripheral nerves makes the detection of NF-like proteins 
in Schwann cells in vivo a difficult task which probably ex- 
plains why Schwann cell NF-M has been overlooked until 
now. It should be emphasized however that mRNA encoding 
NF-M  was  detected by Northern blotting in sciatic nerve 
(Fig. 7). Why differentiating Schwann cells should synthe- 
size a NF-like protein remains unclear. Equally puzzling is 
why Schwann cells synthesize NF-M alone of the NF triplet 
since these proteins are normally coordinately expressed in 
neurons. At any rate, the possibility that NF-like proteins ex- 
ist in other nonneuronal cells should now be considered seri- 
ously. 
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